| P50 | author | Byung G. Kim | Q37381959 |
| | Young Chul Youn | Q57011074 |
| | So Young Moon | Q92092891 |
| P2093 | author name string | Tae Sung Lim | |
| | Jun Young Choi | |
| | Hyun Young Lee | |
| | In Soo Joo | |
| | Kyoon Huh | |
| | Sun Ah Park | |
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| | Normative data on the Korean version of the Boston Naming Test | Q31379359 |
| | Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates | Q33591798 |
| | Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients | Q33935344 |
| | Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology | Q34242658 |
| | SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. | Q34260303 |
| | Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. | Q34532650 |
| | Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis | Q35183975 |
| | Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response | Q35457439 |
| | Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting | Q36142895 |
| | Diagnosing idiopathic normal-pressure hydrocephalus. | Q36256448 |
| | Frequent amyloid deposition without significant cognitive impairment among the elderly | Q37085957 |
| | The role of the neurologist in the longitudinal management of normal pressure hydrocephalus. | Q37769055 |
| | Impact of white matter changes on activities of daily living in mild to moderate dementia. | Q38475680 |
| | Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus | Q41823194 |
| | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Q42062882 |
| | Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus | Q43580506 |
| | CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Q45923691 |
| | The longitudinal profile of CSF markers during external lumbar drainage. | Q45965064 |
| | CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. | Q46961181 |
| | Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study | Q47663103 |
| | Immunoreactivities of amyloid beta peptide((1-42)) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus | Q48021362 |
| | Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. | Q48208608 |
| | Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus | Q48348912 |
| | CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings | Q48559548 |
| | Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting? | Q48825303 |
| | Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke | Q49117210 |
| | Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization | Q49169032 |
| | Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. | Q51867713 |
| | Cognitive and motor improvement after retesting in normal-pressure hydrocephalus: a real change or merely a learning effect? | Q51868517 |
| | The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders. | Q51926890 |
| | Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. | Q51983988 |
| | Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? | Q53212854 |
| | Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings | Q74124818 |
| | Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease | Q79652573 |
| | Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease | Q82060363 |
| | Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus | Q83716415 |
| | Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers | Q86370822 |
| | Profile of cognitive dysfunction and relation with gait disturbance in Normal Pressure Hydrocephalus | Q87294816 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | hydrocephalus | Q193003 |
| | biomarker | Q864574 |
| | idiopathic normal pressure hydrocephalus | Q28735834 |
| P304 | page(s) | 66 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | BMC Neurology | Q15763734 |
| P1476 | title | Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers | |
| P478 | volume | 14 | |